Medications

US company withdraws ALS drug after it fails in trial

Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.

Health

Japan dietary supplement maker probes five deaths

A Japanese drugmaker said on Friday it is investigating five deaths potentially linked to dietary supplements meant to lower cholesterol and apologized for the "anxiety and fear" it had caused.

page 2 from 40